Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Non-Current Assets (2016 - 2026)

Standard Biotools has reported Non-Current Assets over the past 16 years, most recently at $46.0 million for Q4 2025.

  • Quarterly Non-Current Assets fell 6.76% to $46.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.0 million through Dec 2025, down 6.76% year-over-year, with the annual reading at $46.0 million for FY2025, 6.76% down from the prior year.
  • Non-Current Assets was $46.0 million for Q4 2025 at Standard Biotools, down from $67.2 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $235.6 million in Q1 2025 and troughed at $46.0 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $188.1 million (2022), against an average of $158.7 million.
  • Year-over-year, Non-Current Assets skyrocketed 35.24% in 2024 and then crashed 77.73% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $203.1 million in 2021, then tumbled by 70.69% to $59.5 million in 2022, then fell by 7.87% to $54.8 million in 2023, then decreased by 10.04% to $49.3 million in 2024, then dropped by 6.76% to $46.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Non-Current Assets are $46.0 million (Q4 2025), $67.2 million (Q3 2025), and $50.9 million (Q2 2025).